Mag-aso, Mia Jane .
HRN: 18-98-23 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CO-AMOXICLAV 625MG (TAB)
07/01/2026
07/07/2026
ORAL
625mg
BID
UTI
Checking Initial Appropriateness